NCT03199261: A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects |
|
|
| Completed | 1 | 24 | RoW | rE-4 Injection, Recombinant Exendin-4 Injection, rE-4 Freeze-dried Powder, Recombinant Exendin-4 Freeze-dried Powder | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Type 2 Diabetes | 01/17 | 01/17 | | |
